Re-irradiation and hyperthermia after surgery for recurrent breast cancer

M Linthorst, AN Geel, M Baaijens, Abdelali Ameziane, W Ghidey, Gerard van Rhoon, Cobi Zee

Research output: Contribution to journalArticleAcademicpeer-review

63 Citations (Scopus)


Purpose: Evaluation of efficacy and side effects of combined re-irradiation and hyperthermia electively or for subclinical disease in the management of locoregional recurrent breast cancer. Methods and materials: Records of 198 patients with recurrent breast cancer treated with re-irradiation and hyperthermia from 1993 to 2010 were reviewed. Prior treatments included surgery (100%), radiotherapy (100%), chemotherapy (42%), and hormonal therapy (57%). Ninety-one patients were treated for microscopic residual disease following resection or systemic therapy and 107 patients were treated electively for areas at high risk for local recurrences. All patients were re-irradiated to 28-36 G Results: The median follow-up was 42 months. Three and 5 year LC-rates were 83% and 78%. Mean of T90 (tenth percentile of temperature distribution), maximum and average temperatures were 39.8 degrees C, 43.6 degrees C, and 41.2 degrees C, respectively. Mean of the cumulative equivalent minutes (CEM43) at T90 was 4.58 min. Number of previous chemotherapy and surgical procedures were most predictive for LC. Cumulative incidence of grade 3 and 4 late toxicity at 5 years was 11.9%. The number of the Conclusions: The combination of re-irradiation and hyperthermia results in a high LC-rate with acceptable toxicity. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
Original languageUndefined/Unknown
Pages (from-to)188-193
Number of pages6
JournalRadiotherapy and Oncology
Issue number2
Publication statusPublished - 2013

Research programs

  • EMC MM-03-32-05

Cite this